Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT). Both saw their shares more than double in 2024, ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Viking Therapeutics stock plunged early Thursday on an earnings report that included mostly incremental updates for its ...

Lilly began marketing tirzepatide as Mounjaro for diabetes patients in 2022, then as Zepbound for weight management ... tentatively named VK2735, reduced obesity patients' weight by 14.7% after ...

VK2735 is a dual GLP-1/GIP medicine, the same class as Eli Lilly's Zepbound. While that doesn't guarantee success, the company could make even more progress in 2025. Viking Therapeutics should ...

VK2735 is a dual GLP-1/GIP medicine, the same class as Eli Lilly's Zepbound. While that doesn't guarantee success, the company could make even more progress in 2025. Where to invest $1,000 right now?

Zepbound is a subcutaneous injection that needs proper storage and handling during travel. There are ways you can travel with Zepbound to ensure it remains safe and effective to use. Zepbound ...

Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion. The drugmaker ...